河北医科大学第二医院人员卷入11年耗材腐败案 收受回扣1.84亿元
Hebei hospital staff pocket 184 million yuan in medical implant bribes across 11-year kickback scheme
- 河北医科大学第二医院医务人员在11年间，通过系统性索贿手段侵吞了高达1.84亿元人民币（约2600万美元）的商业回扣。 Staff at Hebei Medical University Second Hospital systematically extorted 184 million yuan ($26M USD) in commercial kickbacks across 11 years.
- 外科医生每植入一枚进口心脏支架即可直接入账5000元现金，起搏器和人工晶状体等耗材也均明码标价提取分成。 Surgeons pocketed 5,000 yuan in direct cash per imported cardiac stent, with corresponding kickbacks on pacemakers and intraocular lenses.
- 涉案交易达46笔，涉及30家商业供货商，且长期在同谋科室负责人的直接庇护与纵容下运作。 Involved 46 illicit transactions with 30 commercial vendors under the direct supervision of complicit department leadership.
- 这起案件凸显周期性反腐风暴往往沦为“表演式替罪”，未能触及公立医疗垄断背后的体制性诱因。 Demonstrates how periodic anti-corruption campaigns use performative scapegoating without addressing state hospital monopoly incentives.
新浪新闻引述案件通报称，河北医科大学第二医院多名科室负责人长达十一年间操纵进口心脏植入耗材的商业回扣网络[1]，通过与三十家医药供应商进行的四十六笔交易，疯狂侵吞资金达1.84亿元人民币（约合2600万美元）。主刀医生每植入一枚心脏支架即可索取高达5000元（约合700美元）现金，起搏器和人工晶状体等耗材亦按比例层层抽成[2]。
该案揭开了深植于公立医疗垄断体制内部的系统性腐败与掠夺性寻租[3]。尽管官方反腐运动接连不断，但许多省属医疗机构往往只是通过表演式替罪推脱责任，依然依靠畸高的耗材加价将临床诊疗持续变现。在缺乏患者权益组织与司法维权通道的现实下，体制性财政扭曲的沉重代价被直接转嫁给普通病患，而根本性的结构性病灶却始终未被触及。
For eleven years, department heads at Hebei Medical University Second Hospital ran a commercial kickback scheme on imported cardiac implants [1], skimming 184 million yuan ($26 million) across forty-six transactions with thirty medical vendors, according to filings reported by Sina News. Surgeons pocketed up to 5,000 yuan ($700) in cash for each stent, with kickbacks attached to pacemakers and intraocular lenses [2].
The case uncovers systemic corruption and predatory rent-seeking embedded within state hospital monopolies [3]. Despite periodic anti-corruption campaigns, provincial medical facilities continue to monetize clinical procedures through inflated equipment markups. Without patient advocacy groups or judicial avenues to challenge hospital practices, healthcare costs are passed directly to patients while systemic fiscal imbalances remain unaddressed.
中国社交平台上充斥着民愤与冷嘲：“医生装一个支架就能拿5000块，老百姓进医院哪是在看病，分明是任由公立垄断机构宰割的提款机。”
Bitter reactions across Chinese social media: 'When doctors receive 5,000 yuan per stent, patients aren't receiving medical care—they are being monetized by a state monopoly.'
新浪新闻相关报道下方的微博评论区遭到严格过滤与精选，意在压制公众探讨公立医院垄断地位如何从制度上催生暗箱回扣。
Weibo comment sections on the Sina News report were filtered to prevent discussions examining how the state hospital monopoly structurally drives illicit kickbacks.
尽管自2023年以来全国掀起多轮医疗反腐风暴，但倒逼公立医院自负盈亏的制度机制，依然持续滋生着以药养医和耗材腐败。
Despite repeated national hospital anti-corruption campaigns since 2023, structural incentives forcing public hospitals to self-finance operations continue to spur medical bribery.